Simon Pedder is CEO at Chelsea Therapeutics International, Ltd. (CHTP). They have made 9 open-market trades across 5 companies since 2006, most recently 2020-04-09.
CIK 0001316736
9 open-market purchases totalling $168K since 2006, never a sale. Across 5 scored buys the stock is down 2.5% at ninety days, and 4.9 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 40% | 60% |
| Avg Move | +1.9% | +0.9% | -2.5% |
| Alpha | +1.8% | +1.2% | -4.9% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CERC | BUY | 2019-08-27 | 2019-08-29 | $2.98 | $20K | +6.8% | -2.1% | +6.3% |
| CERC | BUY | 2019-05-14 | 2019-05-16 | $5.06 | $30K | -15.0% | -2.5% | -34.5% |
| ATNX | BUY | 2018-11-14 | 2018-11-14 | $10.26 | $30K | +12.0% | +6.4% | +9.3% |
| ATNX | BUY | 2017-06-19 | 2017-07-28 | $11.00 | $11K | -21.5% | -7.5% | -3.4% |
| CLRB | BUY | 2014-08-20 | 2014-08-22 | $3.75 | $50K | +27.3% | +9.9% | +9.9% |
| CHTP | BUY | 2010-09-02 | 2010-09-07 | $4.08 | $5K | N/A | N/A | N/A |
| CHTP | BUY | 2009-12-17 | 2009-12-21 | $2.20 | $10K | N/A | N/A | N/A |
| CHTP | BUY | 2008-09-24 | 2008-09-24 | $2.91 | $9K | N/A | N/A | N/A |
| CHTP.OB | BUY | 2006-08-23 | 2006-08-24 | $3.27 | $3K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.